MCAM and sarcoma: Taken together, these data show that CD146 reliably identifies a population of cells in sarcoma that are enriched for TPCs, which are characterized by enhanced tumorigenicity, the ability to self-renewal, and the ability to initiate tumors that resembles the parent tumor.